FindTrial
Sign In

Study of genetic mutation in metastatic oral cancers

EGFR mutation, EGFR and VEGF expression in fine needle aspiration cytology samples in metastatic oral squamous cell carcinoma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069428
Enrollment
20
Registered
2024-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C770- Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed cases of nodal metastasis in oral squamous cell carcinoma.

Exclusion criteria

Exclusion criteria: Cases with inadequate material, or with extensive hemorrhage.

Design outcomes

Primary

MeasureTime frame
1) Prevalence of expression of EGFR and VEGF in metastatic oral squamous cell carcinoma 2) Expression of EGFR mutations in metastatic oral squamous cell carcinomaTimepoint: Baseline—

Secondary

MeasureTime frame
Correlation between expression of EGFR and VEGF and EFGR mutations with response to therapyTimepoint: Baseline—

Countries

India

Contacts

Public ContactDr Meeta Singh

Maulana Azad Medical College

meetamamc@gmail.com9968604327

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026